Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,819 | -62,412 | -188,917 | -134,406 | -88,256 |
| Depreciation Amortization | 524 | 116 | 383 | 280 | 181 |
| Accounts receivable | -9,136 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,868 | 2,204 | 2,316 | 3,131 | 4,305 |
| Other Working Capital | 51,952 | 1,215 | 9,418 | 5,617 | 6,592 |
| Other Operating Activity | -79,247 | 9,148 | 29,947 | 19,897 | 8,761 |
| Operating Cash Flow | $-98,858 | $-49,729 | $-146,853 | $-105,481 | $-68,417 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,471 | 89,288 | 131,602 | 101,214 | 9,256 |
| PPE Investments | -26 | N/A | -224 | -216 | -175 |
| Purchase Sale Intangibles | -17,100 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 90,900 | 0 | -3,000 | -3,000 | 0 |
| Investing Cash Flow | $106,345 | $89,288 | $128,378 | $97,998 | $9,081 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,345 | 48 | 162,747 | 162,747 | 162,632 |
| Other Financing Activity | 0 | 0 | 1,250 | 653 | 653 |
| Financing Cash Flow | $1,345 | $48 | $163,997 | $163,400 | $163,285 |
| Beginning Cash Position | 230,784 | 230,784 | 85,262 | 85,262 | 85,262 |
| End Cash Position | 239,616 | 270,391 | 230,784 | 241,179 | 189,211 |
| Net Cash Flow | $8,832 | $39,607 | $145,522 | $155,917 | $103,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,858 | -49,729 | -146,853 | -105,481 | -68,417 |
| Capital Expenditure | -26 | N/A | -224 | -216 | -175 |
| Free Cash Flow | -98,884 | -49,729 | -147,077 | -105,697 | -68,592 |